Table 9.6a

Immunosuppression Use for Induction, 1993 to 2002

Recipients with Liver Transplants

	Year of Transplant
	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants	3,440	3,652	3,934	4,080	4,186	4,517	4,744	4,979	5,187	5,326
Tx With Immunosuppression Info	2,853	3,105	3,380	3,515	3,855	4,169	4,391	4,803	5,004	5,101
No Induction Drugs Recorded	99.2%	86.7%	85.7%	90.0%	93.0%	91.0%	86.7%	84.4%	84.5%	82.4%
Drugs	0.0%	0.0%	0.0%	0.0%	-	-	-	-	-	-
ALG
ATG	0.2%	4.6%	4.5%	3.6%	2.1%	1.2%	0.7%	0.6%	0.4%	0.5%
NRATG/NRATS	-	-	-	0.0%	0.0%	0.0%	-	0.0%	-	-
OKT3	0.6%	8.7%	9.9%	6.5%	4.9%	3.6%	1.4%	0.8%	0.7%	0.3%
Thymoglobulin	-	-	-	-	-	0.1%	0.5%	1.2%	2.4%	4.3%
Zenapax	-	-	-	-	0.0%	2.9%	6.5%	6.7%	5.9%	4.6%
Simulect	0.0%	0.0%	0.0%	0.0%	0.1%	1.4%	4.4%	6.7%	6.3%	8.0%

Source: OPTN/SRTR Data as of August 1, 2003.

(-) = Drug not used anytime during the year.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.